跳至主要内容
临床试验/NL-OMON56447
NL-OMON56447招募中不适用

oninvasive electrocardiographic imaging for individuals at risk for apparently idiopathic ventricular fibrillation - VIGILANCE

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 550 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
550

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • In order to be eligible to participate in this study, a subject must be >= 18
  • years old and meet one of the following criteria:- All unexplained polymorphic
  • VT or VF survivors in whom known structural myocardial, respiratory, metabolic
  • and toxicological causes have been excluded through clinical evaluation*,
  • with/without a genetic mutation.
  • NB. If results of a diagnostic tests show minor abnormalities but insufficient
  • for a specific diagnosis, this is no exclusion criterion.
  • - Selected family members of these patients*
  • - Control subjects with structurally normal hearts with a clinical indication
  • for a cardiac CT scan, as already approved in METC protocol NL32128.068.11 (ABR
  • number 32128). *All 1st and 2nd degree family members being in contact with the
  • cardiologist/treating physician as part of cascade screening will be contacted.
  • Family members must be in adequate health to be able to travel to the hospital
  • for research purposes. 3rd degree family members in contact with the
  • cardiologist/treating physician can also be contacted if at least one of the
  • following criteria is met:
  • The family member has the same genetic mutation as index patient, or;
  • The family member has demonstrated ventricular arrhythmias, or;
  • The clinician has a very strong suspicion of ventricular arrhythmias in the
  • family member.

排除标准

  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this study:- A known strong reaction against electrode
  • attachment or contrast agent.
  • - Any serious medical condition, which in the opinion of the investigator, may
  • adversely affect the safety and/or effectiveness of the participant or the
  • - Pregnancy, nursing or planning to be pregnant.
  • - Subject has an estimated glomerular filtration rate (eGFR) of
  • <30mL/min/1.73m2, using the MDRD calculation.
  • - Unability to give informed consent.
  • - Family members of a patients with idiopathic unexplained polymorphic VT/VF ,
  • who have severe cardiac abnormalities and/or disease not related to the
  • symptoms or phenotype of the index patients and which may have a negative
  • influence on results of ECGI according to local investigators.

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验